{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T21:19:47Z","timestamp":1775337587761,"version":"3.50.1"},"reference-count":93,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T00:00:00Z","timestamp":1221004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract.<\/jats:title><jats:p>Bisphosphonates are the current mainstay of treatment for postmenopausal osteoporosis. Although daily oral dosing is effective, it is associated with poor compliance, partly because of the pre and postdose fasting and posture requirements. This negatively impacts treatment outcomes, leading to a reduced clinical benefit. Improved, yet still suboptimal adherence has been noticed with less frequent bisphosphonate dosing e.g. once\u2010weekly and once\u2010monthly oral regimens. The recently approved quarterly intravenous (i.v.) injection regimen of ibandronate and yearly i.v. infusion of zoledronic acid are attractive options in the management of postmenopausal osteoporosis. These regimens may assure quarterly and year long compliance.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2008.02010.x","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T18:59:52Z","timestamp":1221073192000},"page":"315-332","source":"Crossref","is-referenced-by-count":35,"title":["Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance"],"prefix":"10.1111","volume":"264","author":[{"given":"S.","family":"Boonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Venken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Milisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Delforge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Haentjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,9,10]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02738966"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012470862-4\/50017-9"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004164"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69870-8"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012470862-4\/50073-8"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.21.2.115"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(99)00116-7"},{"key":"e_1_2_5_9_2","first-page":"711","article-title":"Nitrogen\u2010containing bisphosphonate mechanism of action","volume":"4","author":"Reszka AA","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0843"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(24)38786-5","article-title":"Structure\u2010activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen\u2010containing bisphosphonates","volume":"296","author":"Dunford JE","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.05.003"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M412817200"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-69870-8"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2002.6510"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000615)88:12 <2961::AID-CNCR12>3.0.CO;2-L"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040325"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1602-9"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030897"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00946-8"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8415"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.6.1051"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301243"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01124-X"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.1.6267"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0954-6820.2003.01258.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-005-1945-x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200084"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980200125"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511303332201"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00004171"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102013440503"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001980170006"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.18.2237"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52506.x"},{"key":"e_1_2_5_40_2","first-page":"1968","article-title":"Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age","volume":"32","author":"Ettinger MP","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(02)00869-4"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2006.01.011"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.12927\/hcq..16941"},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100"},{"key":"e_1_2_5_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0073-6"},{"key":"e_1_2_5_46_2","volume-title":"Adherence to long\u2010term therapies: evidence for action","author":"Sabat\u00e9 E","year":"2003"},{"key":"e_1_2_5_47_2","article-title":"Persistence with bisphosphonate therapy and the impact of dosing frequency in patients with post\u2010menopausal osteoporosis","volume":"7","author":"Penning\u2010van Beest FJAGW","year":"2004","journal-title":"Value Health"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2006.07.003"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1502-4"},{"key":"e_1_2_5_50_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.8.1013"},{"issue":"1","key":"e_1_2_5_51_2","article-title":"Longer term effectiveness outcomes of noncompliance and nonpersistence with daily regimen bisphosphonate therapy in patients with osteoporosis treated in tertiary specialist care","volume":"15","author":"Sebaldt RJSL","year":"2004","journal-title":"Osteoporos Int"},{"key":"e_1_2_5_52_2","article-title":"Adherence to bisphosphonates (BPs) is associated with reduced fracture risk in women with postmenopausal osteoporosis (PMO)","volume":"12","author":"Siris ES","year":"2005","journal-title":"Menopause"},{"key":"e_1_2_5_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.01.150"},{"key":"e_1_2_5_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80109-0"},{"key":"e_1_2_5_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)87974-6"},{"key":"e_1_2_5_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03339822"},{"key":"e_1_2_5_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-002-2011-8"},{"issue":"3","key":"e_1_2_5_58_2","article-title":"Persistence and compliance with daily\u2010 and weekly\u2010administered bisphosphonates in German women with osteoporosis","volume":"64","author":"Bartl RGS","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"e_1_2_5_59_2","article-title":"Analysis of non\u2010adherence with bisphosphonate treatment for osteoporosis in UK patients","volume":"00","author":"Cowell WCA","year":"2005","journal-title":"Bone"},{"key":"e_1_2_5_60_2","article-title":"Persistence with bisphosphonate therapy and the impact of dosing frequency in patients with postmenopausal osteoporosis","volume":"7","author":"Penning\u2010van Beest FJA","year":"2004","journal-title":"Value Health"},{"key":"e_1_2_5_61_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X61875"},{"key":"e_1_2_5_62_2","first-page":"S513","article-title":"Medication persistence is improved with less frequent dosing of bisphosphonates, but remains inadequate","volume":"50","author":"Ettinger MPGR","year":"2004","journal-title":"Arthritis Rheum"},{"key":"e_1_2_5_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)80085-6"},{"key":"e_1_2_5_64_2","first-page":"31","article-title":"Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study","volume":"30","author":"Simon JABK","year":"2005","journal-title":"Female Patient"},{"key":"e_1_2_5_65_2","first-page":"341","article-title":"A bright future for osteoporosis treatment","volume":"18","author":"Jack D","year":"2005","journal-title":"Drug News Perspect"},{"key":"e_1_2_5_66_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1750"},{"key":"e_1_2_5_67_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.050313"},{"key":"e_1_2_5_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.044958"},{"key":"e_1_2_5_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0531-9"},{"key":"e_1_2_5_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.09.001"},{"key":"e_1_2_5_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01059.x"},{"key":"e_1_2_5_72_2","unstructured":"EmkeyRM Ragi\u2010EisS SedaratiF LeighC EpsteinS.Tolerability of monthly ibandronate and weekly alendronate in women with postmenopausal osteoporosis: results from the Motion Study. Presented at the American College of Rheumatology Poster Number: 159 Boston MA November 6\u201311 2007."},{"key":"e_1_2_5_73_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X253889"},{"key":"e_1_2_5_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.bco.0000141919.24040.91"},{"key":"e_1_2_5_75_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161205774580750"},{"key":"e_1_2_5_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.01.008"},{"key":"e_1_2_5_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(97)00249-0"},{"key":"e_1_2_5_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21918"},{"key":"e_1_2_5_79_2","first-page":"488","article-title":"Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2\u2010year results from the DIVA study","volume":"35","author":"Eisman JA","year":"2008","journal-title":"J Rheum"},{"key":"e_1_2_5_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312"},{"key":"e_1_2_5_81_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa074941"},{"key":"e_1_2_5_82_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.070906"},{"key":"e_1_2_5_83_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.193"},{"key":"e_1_2_5_84_2","doi-asserted-by":"publisher","DOI":"10.14219\/jada.archive.2008.0017"},{"key":"e_1_2_5_85_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0707onj"},{"key":"e_1_2_5_86_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"e_1_2_5_87_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.8670"},{"key":"e_1_2_5_88_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2465"},{"issue":"18","key":"e_1_2_5_89_2","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"24","author":"Hoff AO","year":"2006","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0502-1"},{"key":"e_1_2_5_91_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060712"},{"key":"e_1_2_5_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.04.009"},{"key":"e_1_2_5_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.01.016"},{"key":"e_1_2_5_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.03.011"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2008.02010.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2008.02010.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:05:46Z","timestamp":1738361146000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2008.02010.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,10]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1365-2796.2008.02010.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2008.02010.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,10]]}}}